Interim analysis of a prospective, randomized trial of vacuum-assisted closure versus the healthpoint system in the management of pressure ulcers

被引:140
作者
Ford, CN [1 ]
Reinhard, ER [1 ]
Yeh, D [1 ]
Syrek, D [1 ]
de las Morenas, A [1 ]
Bergman, SB [1 ]
Williams, S [1 ]
Hamori, CA [1 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1097/00000637-200207000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Twenty-eight patients with 41 full-thickness decubitus ulcers were randomized to compare the Vacuum-Assisted Closure device (VAC) with the Healthpoint System (HP) of wound gel products in promoting ulcer healing. A total of 22 patients with 35 full-thickness ulcers completed the 6-week trial of treatment, during which time 2 patients (10%) in the VAC group (N = 20) and 2 patients (13%) in the HIP group (N = 15) healed completely. The mean percent reduction in ulcer volume was 42.1% with HIP and 51.8% with VAC (P = 0.46). The mean number of PMNs and lymphocytes per high-power field decreased in the VAC group and increased in the HIP group (p = 0.13, p = 0.41 respectively). The mean number of capillaries per high-power field was greater in the VAC group (p = 0.75). There were 15 cases of biopsy-proven osteomyelitis underlying the ulcers; three (37.5%) improved with VAC and none improved with HP (p = 0.25). VAC promotes an increased rate of wound healing and favorable histological changes in soft tissue and bone compared with HP.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 13 条
[1]   Vacuum-assisted closure: A new method for wound control and treatment: Clinical experience [J].
Argenta, LC ;
Morykwas, MJ .
ANNALS OF PLASTIC SURGERY, 1997, 38 (06) :563-576
[2]   RISK-FACTORS FOR PRESSURE SORES - A COMPARISON OF CROSS-SECTIONAL AND COHORT-DERIVED DATA [J].
BERLOWITZ, DR ;
WILKING, SV .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (11) :1043-1050
[3]  
BERLOWITZ DR, 1997, J GERONTOL A-BIOL, V52, P106
[4]  
BREASTED JH, 1930, TRANSLATION COMMENTA, P78
[5]  
BROWNETRIS M, 1999, 1999 S ADV WOUND CAR
[6]  
Joseph E, 2000, WOUNDS, V12, P60
[7]   Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers [J].
Kallianinen, LK ;
Hirshberg, J ;
Merchant, B ;
Rees, RS .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 106 (06) :1243-1248
[8]  
KRIZEK TJ, 1999, PLASTIC SURG SECRETS, P29
[9]   THE DIAGNOSIS OF OSTEOMYELITIS IN PATIENTS WITH PRESSURE SORES [J].
LEWIS, VL ;
BAILEY, MH ;
PULAWSKI, G ;
KIND, G ;
BASHIOUM, RW ;
HENDRIX, RW .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1988, 81 (02) :229-232
[10]  
Miller H., 1994, COST IMPLICATIONS PR